235 related articles for article (PubMed ID: 33844717)
1. [SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease].
Samaniego F; Conte G
Rev Med Chil; 2020 Oct; 148(10):1467-1474. PubMed ID: 33844717
[TBL] [Abstract][Full Text] [Related]
2. [COVID-19-associated coagulopathy].
Morishita E
Rinsho Ketsueki; 2021; 62(8):1236-1246. PubMed ID: 34497212
[TBL] [Abstract][Full Text] [Related]
3. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
[TBL] [Abstract][Full Text] [Related]
4. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
5. [Coagulopathies, thrombotic risk and anticoagulation in COVID-19].
Peters P; Sprynger M; Lancellotti P; Oury C
Rev Med Liege; 2020 Sup; 75(S1):86-93. PubMed ID: 33211428
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
D'Souza R; Malhamé I; Teshler L; Acharya G; Hunt BJ; McLintock C
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1110-1120. PubMed ID: 32678949
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Thrombosis: Clinical Aspects.
Urano T; Yasumoto A; Yokoyama K; Horiuchi H; Morishita E; Suzuki Y
Curr Drug Targets; 2022; 23(17):1567-1572. PubMed ID: 36200150
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 coagulopathy - what should we treat?
Chowdary P
Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
[TBL] [Abstract][Full Text] [Related]
9. Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
Sugiyama Y; Tsuchiya T; Tanaka R; Ouchi A; Motoyama A; Takamoto T; Hara N; Yanagawa Y
J Clin Neurosci; 2020 Sep; 79():30-32. PubMed ID: 33070913
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Peripheral Artery Thrombosis: A Mini Review.
Goudarzi E; Yousefimoghaddam F; Ramandi A; Khaheshi I
Curr Probl Cardiol; 2022 Oct; 47(10):100992. PubMed ID: 34571103
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-induced coagulopathy: Experience, achievements, prospects.
Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
[TBL] [Abstract][Full Text] [Related]
14. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
[TBL] [Abstract][Full Text] [Related]
15. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
Dybowska M; Wyrostkiewicz D; Opoka L; Lewandowska K; Sobiecka M; Tomkowski W; Szturmowicz M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142282
[TBL] [Abstract][Full Text] [Related]
16. The risk of thrombosis after acute-COVID-19 infection.
Zuin M; Rigatelli G; Zuliani G; Roncon L
QJM; 2021 Nov; 114(9):619-620. PubMed ID: 33720351
[TBL] [Abstract][Full Text] [Related]
17. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
18. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
[No Abstract] [Full Text] [Related]
20. COVID-19 and thrombosis: Prophylaxis and management.
Canoğlu K; Şaylan B; Çalışkan T
Tuberk Toraks; 2021 Jun; 69(2):269-278. PubMed ID: 34256519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
